key: cord-0761439-n1y5hoqk
authors: Daly, Samuel R; V Nguyen, Anthony; Zhang, Yilu; Feng, Dongxia; Huang, Jason H
title: The Relationship Between COVID-19 Infection and Intracranial Hemorrhage: A systematic review
date: 2021-11-11
journal: Brain Hemorrhages
DOI: 10.1016/j.hest.2021.11.003
sha: 60bea8c70dd19e031b1cf2907016d1e50c5d33fd
doc_id: 761439
cord_uid: n1y5hoqk

nan

Thirty-three articles were identified in the literature search that reported descriptive statistics on the incidence, distribution, and mortality rates of intracranial hemorrhage in various subgroups of patients with Covid-19. (Table 1) Fifteen studies reported on these statistics in all hospitalized Covid-19 patients over a defined period of time. The rate of intracranial hemorrhage in this subgroup was reported to be between 0.1% and 3.3% (for patients >80 years old, the rate was reported at 6.8%). 73 Nine of the studies included information on the distribution of types of intracranial hemorrhage in this population, which included SAH, IPH, intraventricular hemorrhage (IVH), hemorrhagic conversion of ischemic stroke, SDH, and multi-compartment hemorrhage (MCH). In studies with more than one death, the mortality rate for hospitalized Covid-19 with intracranial hemorrhage was reported to be between 50% and 84.6%.

Five studies reported the distribution of types of intracranial hemorrhages in cohorts of patients with Covid-19. SAH and IPH represented the majority of cases in these studies, although SDH and MCH was also reported. Mortality in these cohorts was reported to be between 42.9% and 58%.

There were eight studies that analyzed these statistics in hospitalized Covid-19 patients that had some form of brain imaging. The reported incidence of intracranial hemorrhage in this subgroup was between 2.9% and 11.8%, and was associated with older age, mechanical ventilation, and therapeutic anticoagulation. 68 The mortality of hospitalized Covid-19 patients with intracranial hemorrhage in this subgroup was 29% to 42%.

Four studies included only patients on extracorporeal membrane oxygenation (ECMO) for Covid-19. They reported the rate of intracranial hemorrhage in these patients to be 16% to 42%. Of note, the rate of intracranial hemorrhage in this subgroup of patients is much higher than the rate of cerebral hemorrhage associated with veno-venous ECMO in adults for respiratory failure (3.6%). 66 The reported mortality rate of patients on ECMO for Covid-19 with an intracranial hemorrhage was 75% to 82%.

There were nineteen studies within the literature search that specifically discussed SAH in patients with Covid-19. One was a large study was done to evaluate the risk of developing SAH during Covid-19 infections by analyzing the de-identified Covid-19 dataset from Cerner. 77 The authors interesting did not find an increased risk of SAH in Covid-19 positive patients compared to Covid-19 negative patients (0.1% vs. 0.2%). However, there was a significantly increased risk of morbidity and inhospital mortality in Covid-19 positive patients with SAH compared to those without Covid-19 (31.4% vs. 12.2%).

The remaining 18 studies report data on a total of 33 patients, who suffered SAH during Covid-19 infection. (Table 2 ) There were 9 patients who had an aneurysmal SAH, of which at least 4 were symptomatic from Covid-19. One of the 6 with reported outcomes died. The most common location for the aneurysm was the posterior communicating artery (N = 3). Fourteen patients were reported to have non-aneurysmal spontaneous SAH, of which ten were symptomatic from Covid-19. Five of the 10 patients with symptomatic Covid-19 died. All three with asymptomatic Covid-19 died, and two of the deaths were from subsequent respiratory failure.

One case series is not included in Table 2 , because data for the patients is largely aggregated. 32 This case series reports on ten patients with aneurysmal SAH and active or recent Covid-19 diagnosis that presented to one of five cerebrovascular centers over 10 months. Three of the ten patients had severe Covid-19, and four were asymptomatic. Five patients had saccular aneurysms, four had dissecting pseudoaneurysms, and one had a blister aneurysm. Two patients underwent surgical clipping, four underwent aneurysm coiling, three underwent flow diversion, and one patient died prior to treatment. Two of the ten patients died (both had high grade SAH), and seven were discharged with mRS 0-2.

There were nine studies identified that reported information on seventeen patients, who were in the hospital with respiratory symptoms related to Covid-19, and subsequently developed IPH. (Table  3 ) Ten of the seventeen patients were male (58%), and the patients were between the ages of 38 and 74. Thirteen patients were intubated, and four were on ECMO. All seventeen of the patients were on some form of anticoagulation, and thirteen of the seventeen were on therapeutic anticoagulation (76%). The most common type of IPH was unilateral lobar (N = 9), followed by unilateral lobar with intraventricular extension (IVE) (N = 2), bilateral lobar (N = 2), and focal IPH (N = 2, corpus callosum and posterior fossa). One patient had a bilateral lobar IPH with IVE. Mortality was reported in 9 of the 15 patients for whom outcome was reported (mortality rate 60%). Of the six with reported outcome that did not die, two discharged to rehabilitation (one with severe deficits), three had a reported modified Rankin Scale (mRS) of 5, one had a reported mRS of 4.

Five studies were identified that reported information on seven patients, who presented to the hospital with neurologic symptoms related to IPH and were found to have asymptomatic Covid-19. (Table 3 ) Three patients presented to the hospital with primary neurologic symptoms, and each was found to have an IPH of variable severity. The patient with the brain stem hemorrhage died, the patient with the frontal lobe IPH discharged with mRS 5, and the patient with the olfactory gyrus hemorrhage recovered. A case series reported three patients, who had positive pre-operative Covid-19 PCR tests, and subsequently died from IPH after cranial biopsies. 30 Of note, Anti-SARS-Cov tests were negative on cerebral samples from all three patients. The authors reported that 28 cranial biopsies had been done on Covid-19 negative patients during the same time, and none of those patients had any complication. The final study describes a newborn child born at 33 weeks due to pre-term labor, who was found to have bilateral cortical hemorrhages. 34 The patient had a negative PCR test for Covid-19, but maternal serum was positive for IgG of the SARS-CoV-2 S1-protein and N-protein.

Two patients were identified in two separate articles that suffered a SDH during a Covid-19 infection. The first was in a case report of a 50-year-old Covid-19 positive male admitted for treatment of newly diagnosed acute promyelocytic leukemia, who developed an acute SDH with 12mm of midline shift. He underwent decompressive craniotomy and passed away after surgery due to disseminated intravascular coagulopathy (DIC). The authors concluded that the SDH would have been unlikely without a simultaneous diagnosis of Covid-19. 39 The second case was identified in a single institution case series of Covid-19 patients with a devastating neurologic outcome. This patient was a 68-year-old female, who was incidentally found to be Covid-19 positive, and presented with a spontaneous SDH, requiring neurosurgical decompression. She suffered a post-operative IPH likely due to a cortical vein thrombosis, but she was eventually discharged to rehabilitation. 70 

Five studies reported on eight Covid-19 patients, who developed simultaneous MCH ( Table 4 ). Seven of the 8 patients presented with respiratory symptoms. Within that group, five were male, and they were all between the ages of 59 and 76. Five of those patients died (mortality rate 71%), and two were discharged to rehabilitation. Of those with primary respiratory symptoms, four were on some form of anticoagulation and/or antiplatelet medications. The most common combination of hemorrhages was IPH/SAH (N=4), followed by IPH/SAH/SDH (N=2) and SAH/SDH (N=1).

One patient (36-year-old male) presented primarily with neurologic symptoms and was found to have a multicompartment hemorrhage (IPH/SAH/SDH). 5 He required neurosurgical decompression, and Covid-19 RNA was present in his cerebrospinal fluid (CSF). His outcome was not reported.

There were 16 studies identified that included a total of 17 patients with either active or recent Covid-19 infection, who had cerebral venous thrombosis (CVT) associated with intracranial hemorrhage. There were also three large studies discovered by the search that reported statistics on patients with Covid-19 and cerebral venous sinus thrombosis (CVST). One study was done over nine months and identified eight patients that met this inclusion criteria, of which 2 had associated intracranial hemorrhage (25%). The authors also conducted a literature review on this topic and reported that 6 of the 33 patients identified in the literature had an associated intracerebral hemorrhage (18%). Another study conducted across three academic centers identified six patients with Covid-19 and CVST, of which four had associated hemorrhagic parenchymal lesions (66.7%). 75 The third study was done across nine tertiary care stroke centers and identified 13 patients with Covid-19 and CVST, of which four had associated IPH (31.7%). 71 Of note, the authors of that article report that this is the same rate of associated hemorrhage in a historical group of patients with CVST.

The literature search identified 12 studies with 13 patients, who had active Covid-19 infection and developed an intracranial hemorrhage related to a CVT. (Table 5 ) The patients ranged in age from 13 to 75 years old, and 50% (6 of 12) were female. Four patients were in the hospital for respiratory symptoms related to Covid-19, of which three were intubated for respiratory failure. The remaining nine patients presented with neurologic symptoms and were found to have asymptomatic Covid-19. None of the patients that presented with neurologic symptoms were reported to be on anticoagulation. The most common thrombosis was found in the transverse and sigmoid sinus (N = 6), followed by superior sagittal sinus (N = 2), and the superior sagittal sinus extending to the transverse and sigmoid sinuses (N = 2). The most common associated hemorrhage was IPH (N = 6), followed by hemorrhagic infarct (N = 4).

There were four studies that each reported on a single patient with a recent Covid-19 infection, who subsequently presented with CVT and associated intracranial hemorrhage. (Table 5 ) All four were male patients, and they were between the ages of 27 and 57 years old. One patient had isolated cortical vein thrombosis, and the other three patients had sinus thrombosis. They presented 2-4 weeks following a Covid-19 infection, and all four patients recovered.

There were five studies that described Covid-19 positive patients with simultaneous ischemic stroke and intracranial hemorrhage, four of which reported the incidence. (Table 6 ) A large retrospective study across 11 New York hospitals looked at the rate of hemorrhagic conversion after ischemic stroke in 10,596 hospitalized Covid-19 patients. 49 They reported that 86 (0.81%) had an ischemic stroke, and that eight of those patients had evidence of simultaneous hemorrhage (0.08%). A second study from a single New York stroke center prospectively followed eight hospitalized Covid-19 patients with ischemic stroke and reported that two had an associated intracranial hemorrhage (25%). 4 Both patients had SAH secondary to cerebral artery dissection, and neither patient had any known risk factors. The third study reported that symptomatic Covid-19 patients with an ischemic stroke had a higher rate of associated intracranial hemorrhage than asymptomatic Covid-19 patients with ischemic stroke (31.7% vs. 4.4%). 48 The remaining two studies reported two cases of Covid-19 patients with simultaneous intracranial hemorrhage and ischemic stroke. (Table 6 ) One was a 64-year-old Covid-19 positive male that presented with neurologic symptoms and was found to have ischemic strokes in the thalamus, temporal lobe, and occipital lobe. 29 He had an associated SAH and was discharged home. The second was in a 5-year-old male on ECMO for Covid-19, who developed a large infarct in the ACA and MCA territory. 50 He had an associated SAH and progressed quickly to brain death.

The search resulted in six studies discussing hemorrhagic conversion of ischemic stroke in patients with Covid-19, three of which analyzed the incidence of these bleeds. (Table 6 ) The large retrospective study mentioned in the previous section of 10,596 hospitalized Covid-19 patients reported that of the 86 with an ischemic stroke, six had evidence of hemorrhagic conversion (0.06%). 49 The second study included 34 stroke centers in Europe, and reported data on 93 Covid-19 patients, who underwent mechanical thrombectomy for large vessel occlusions. 18 Of those 93 patients, 23 (25%) had intracranial hemorrhagic conversion within 30 days of MT, and five (5%) were symptomatic. The third study was a case series of 22 Covid-19 patients with acute cerebrovascular disease. They reported that three of the 22 (13.6%) suffered hemorrhagic conversion, and all required neurosurgical decompression. 92 The remaining three studies describe three total cases of Covid-19 patients, who suffered hemorrhagic conversion of an ischemic stroke. (Table 5 ) Two patients were intubated for Covid-19 at the time, and one presented with neurologic symptoms two days after being discharged. One patient was on prophylactic anticoagulation at the time of the stroke. One patient died from the stroke, and one patient died from multi-organ failure related to disseminated intravascular coagulation.

This article provides a systematic review of nearly 100 PubMed indexed articles on the association between Covid-19 and intracranial hemorrhage. Among all hospitalized Covid-19 patients, the rate of intracranial hemorrhage is reported here to be between 0.1% and 3.3%, and it likely increases for patients greater than 80 years old. The data reviewed here suggests that the development of an intracranial hemorrhage during Covid-19 infection is associated with increased rates of morbidity. These patients have a longer length of hospital stay, are more likely to require ICU level care, are more likely to have longer lengths of ICU stay, are more likely to require mechanical ventilation, and are more likely to require vasopressor support. 31, 79 They also have an exceptionally high mortality rate, which is reported in articles included here to be 42-84%.

Nearly all subtypes of intracranial hemorrhage were represented in this literature review, including SAH (both aneurysmal and spontaneous), IPH, SDH, MCH, hemorrhage related to cerebral venous thrombosis, simultaneous hemorrhage with ischemic stroke, and hemorrhagic conversion of ischemic stroke. This suggests that although Covid-19 is associated with an increased risk of intracranial hemorrhage, there does not appear to be a predisposition for a specific subtype of hemorrhage. This also serves to highlight the point that not all intracranial hemorrhage during Covid-19 infection can be attributed to the pathology of the virus. It remains critically important to rule out other etiologies of intracranial hemorrhage in these patients, such as aneurysms, vascular malformations, underlying lesions, and underlying coagulopathy, in order to provide appropriate treatment. 2, 26, 100 The risk factors for developing an intracranial hemorrhage during a Covid-19 infection include therapeutic anticoagulation and mechanical ventilation. 8, 68 There also appears to be an increased rate of mortality for patients who develop an intracranial hemorrhage while on ECMO for Covid-19. Unfortunately, these risk factors may be necessary treatment modalities for Covid-19 infections. Mechanical ventilation and ECMO are often employed in Covid-19 due to acute respiratory distress syndrome, and therapeutic anticoagulation has been shown to improve outcomes in non-critically ill Covid-19 patients. 59 Thus, when caring for Covid-19 patients, careful consideration of the nuanced risks and benefits of these various treatment modalities is clearly necessary. 

Coronavirus disease (COVID-19) pandemic, in: World Health Organizaiton

Intracranial Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series

Neurological emergencies associated with COVID-19: stroke and beyond

Acute Cerebrovascular Disorders and Vasculopathies Associated with Significant Mortality in SARS-CoV-2 Patients Admitted to The Intensive Care Unit in The New York Epicenter

COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Coronavirus Positive Patients Presenting with Stroke-Like Symptoms

Hemorrhagic presentations of COVID-19: Risk factors for mortality

Spontaneous subarachnoidal hemorrhage in patients with Covid-19: case report

Association of pediatric COVID-19 and subarachnoid hemorrhage

Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series

Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection

Increased Intracranial Hemorrhage Amid Elevated Inflammatory Markers in Those With COVID-19 Supported With Extracorporeal Membrane Oxygenation

Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease

Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience

Neuroimaging Findings in Conjunction with Severe COVID-19

European Multicenter Study of ET-COVID-19

Catastrophic Intracranial Hemorrhage in Two Critically Ill Patients with COVID-19

Risk for In-Hospital Complications Associated with COVID-19 and Influenza -Veterans Health Administration, United States

Acute Hemorrhagic Encephalitis Related to COVID-19

Acute spontaneous hematoma of the corpus callosum in a COVID-19 patient: a case report

Neurological manifestations as primary presentation of COVID-19 in hospitalized patients

The COVID-19 emergency does not rule out the diagnostic arsenal in intracerebral hemorrhage: Do not forget the old enemies

Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature

Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection

Concurrent Acute Ischemic Stroke and Non-Aneurysmal Subarachnoid Hemorrhage in COVID-19

Acute Hemorrhage After Intracerebral Biopsy in COVID-19 Patients: Report of 3 Cases

Acute Cerebrovascular Events With COVID-19 Infection

Aneurysmal Subarachnoid Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series

A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation

Severe Brain Damage in a Moderate Preterm Infant as Complication of Post-COVID-19 Response during Pregnancy

Letter: Perioperative and Critical Care Management of a Patient With Severe Acute Respiratory Syndrome Corona Virus 2 Infection and Aneurysmal Subarachnoid Hemorrhage

Intracranial hemorrhage in critically ill patients hospitalized for COVID-19

Spontaneous Brainstem Hemorrhagic Stroke in the Setting of Novel Coronavirus Disease 2019 -A Case Report

Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients

Sudden death of a SARS-CoV-2 patient with NPM1 + acute myeloid leukemia mimicking acute promyelocytic leukemia

Intracranial Hemorrhage in a Patient With COVID-19: Possible Explanations and Considerations

Yield of Head Imaging in Ambulatory and Hospitalized Patients With SARS-CoV-2: A Multi-Center Study of 8675 Patients

Multiorgan Point-of-Care Ultrasound in a Patient With Coronavirus Disease 2019 Pneumonia Complicated by Subarachnoid Hemorrhage and Pulmonary Embolism

Non-aneurysmal subarachnoid haemorrhage in COVID-19

Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series

First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case

A Case of Coronavirus Disease 2019 Presenting with Seizures Secondary to Cerebral Venous Sinus Thrombosis

Cerebral Venous Sinus Thrombosis in a Pediatric Patient With COVID-19

COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers

Cerebrovascular Complications of COVID-19

ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child

Cerebral venous thrombosis in patients with severe COVID-19 infection in intensive care

Pandemic in an 8-Hospital Campus: Observations and Patterns in the Brain, Head and Neck, and Spine

Intracranial hemorrhage in a young COVID-19 patient

Cerebral Sinus Thrombosis Secondary to SARS-CoV-2 Infection

Cerebral venous thrombosis: A typical presentation of COVID-19 in the young

Nervous System Involvement in Coronavirus Disease 2019: Results from a Retrospective Consecutive Neuroimaging Cohort

Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System

Severity of Chest Imaging is Correlated with Risk of Acute Neuroimaging Findings among Patients with COVID-19

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19. medRxiv

Deep cerebral venous sinus thrombosis with transient antiphospholipid antibodies in COVID-19 disease

Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect

Brain and Lung Imaging Correlation in Patients with COVID-19: Could the Severity of Lung Disease Reflect the Prevalence of Acute Abnormalities on Neuroimaging? A Global Multicenter Observational Study

Cerebral Venous Thrombosis in Acute Lymphoblastic Leukemia with Severe COVID-19: a Case Report

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

A Double-Edged Sword: Neurologic Complications and Mortality in Extracorporeal Membrane Oxygenation Therapy for COVID-19-Related Severe Acute Respiratory Distress Syndrome at a Tertiary Care Center

Mild to Severe Neurological Manifestations of COVID-19: Cases Reports

Risk factors for intracerebral hemorrhage in patients with COVID-19

Coronavirus Disease 2019 Complicated by Multiple Simultaneous Intracerebral Hemorrhages

Intracranial Hemorrhage in Hospitalized SARS-CoV-2 Patients: A Case Series

Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series

Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19

Characteristics and Outcomes of Patients 80 Years and Older Hospitalized With Coronavirus Disease 2019 (COVID-19)

Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage

Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review

Hemostatic alterations in COVID-19

Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States

Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States

Clinicopathologic Features of COVID-19: A Case Report and Value of Forensic Autopsy in Studying SARS-CoV-2 Infection

COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center

Acute Cerebrovascular Events in Hospitalized COVID-19 Patients

Aneurysmal subarachnoid hemorrhage in a SARS-CoV-2 positive testing: casual or causal?

Cerebral venous sinus thrombosis after resolution of COVID-19 in a nonhospitalised patient

COVID-19 Respiratory Illness and Subsequent Cerebrovascular Events, the Initial Iranian Experience

Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study

SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

Neurological Complications Among Native Americans with COVID-19: Our Experience at a Tertiary Care Academic Hospital in the U

Aneurysmal subarachnoid hemorrhage in patients with Coronavirus infection: to postpone surgery or not? That is the question

Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry

Neurovascular and perfusion imaging findings in coronavirus disease 2019: Case report and literature review

Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019

Cerebral venous sinus thrombosis associated with COVID-19

Olfactory gyrus intracerebral hemorrhage in a patient with COVID-19 infection

Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex

Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review

A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19

Neurological complications in COVID-19 -a diagnostic challenge

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

CT Fluid-Blood Levels in COVID-19 Intracranial Hemorrhage

COVID-19 pathophysiology: A review

Hemorrhagic stroke in setting of severe COVID-19 infection requiring Extracorporeal Membrane Oxygenation (ECMO)

Immune Thrombocytopenic Purpura in a Patient with Covid-19

Alam, et al. 7 63, M --Death due to Respiratory Failure Craen, et al. 25 66 Abbreviations: M = male, F = female, SAH = subarachnoid hemorrhage, ACA = anterior cerebral artery, MCA = middle cerebral artery, mRS = modified Rankin Score